DaVita HealthCare Partners’ (DVA) Hold Rating Reiterated at KeyCorp

DaVita HealthCare Partners Inc. (NYSE:DVA)‘s stock had its “hold” rating restated by research analysts at KeyCorp in a report issued on Tuesday.

Other analysts have also issued research reports about the company. Jefferies Group LLC reiterated a “hold” rating and set a $70.00 price objective on shares of DaVita HealthCare Partners in a report on Thursday, August 3rd. Zacks Investment Research lowered DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. TheStreet lowered DaVita HealthCare Partners from a “b” rating to a “c+” rating in a report on Wednesday, August 2nd. BidaskClub downgraded DaVita HealthCare Partners from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 5th. Finally, J P Morgan Chase & Co downgraded DaVita HealthCare Partners from a “neutral” rating to an “underweight” rating in a research report on Monday. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $66.50.

DaVita HealthCare Partners (DVA) opened at 54.32 on Tuesday. DaVita HealthCare Partners has a 52 week low of $53.58 and a 52 week high of $70.16. The stock has a market cap of $10.39 billion, a PE ratio of 8.27 and a beta of 0.90. The firm’s 50-day moving average price is $58.47 and its 200-day moving average price is $63.13.

DaVita HealthCare Partners (NYSE:DVA) last posted its earnings results on Tuesday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.02. The company had revenue of $3.88 billion during the quarter, compared to analyst estimates of $3.82 billion. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. DaVita HealthCare Partners’s revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.01 earnings per share. Equities analysts predict that DaVita HealthCare Partners will post $3.59 earnings per share for the current fiscal year.

WARNING: “DaVita HealthCare Partners’ (DVA) Hold Rating Reiterated at KeyCorp” was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.com-unik.info/2017/10/11/davita-healthcare-partners-dva-hold-rating-reiterated-at-keycorp.html.

Institutional investors have recently modified their holdings of the stock. Riverhead Capital Management LLC lifted its stake in DaVita HealthCare Partners by 10.6% in the 2nd quarter. Riverhead Capital Management LLC now owns 112,506 shares of the company’s stock valued at $7,286,000 after buying an additional 10,775 shares in the last quarter. Eqis Capital Management Inc. lifted its stake in DaVita HealthCare Partners by 2.2% in the 2nd quarter. Eqis Capital Management Inc. now owns 4,600 shares of the company’s stock valued at $298,000 after buying an additional 100 shares in the last quarter. Accident Compensation Corp lifted its stake in DaVita HealthCare Partners by 147.5% in the 2nd quarter. Accident Compensation Corp now owns 15,100 shares of the company’s stock valued at $978,000 after buying an additional 9,000 shares in the last quarter. Founders Capital Management LLC lifted its stake in DaVita HealthCare Partners by 0.6% in the 2nd quarter. Founders Capital Management LLC now owns 93,824 shares of the company’s stock valued at $6,076,000 after buying an additional 520 shares in the last quarter. Finally, Jensen Investment Management Inc. lifted its stake in DaVita HealthCare Partners by 24.2% in the 2nd quarter. Jensen Investment Management Inc. now owns 9,740 shares of the company’s stock valued at $631,000 after buying an additional 1,900 shares in the last quarter. 83.27% of the stock is currently owned by hedge funds and other institutional investors.

About DaVita HealthCare Partners

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for DaVita HealthCare Partners (NYSE:DVA)

What are top analysts saying about DaVita HealthCare Partners Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DaVita HealthCare Partners Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit